Clinical advances in the pharmacotherapy of congenital adrenal hyperplasia in: European Journal of Endocrinology Volume 186 Issue 1 (2022)
Genetic disruption of 21-hydroxylase in zebrafish causes interrenal hyperplasia
Adrenal steroidogenesis and congenital adrenal hyperplasia. - Abstract - Europe PMC
Frontiers | 21-Hydroxylase-Specific CD8+ T Cells in Autoimmune Addison's Disease Are Restricted by HLA-A2 and HLA-C7 Molecules
21-Hydroxylase - Wikipedia
Insuffisance surrénalienne CHRONIQUE
Hyperplasie congénitale des surrénales provoquée par un déficit en 21- hydroxylase - Pédiatrie - Édition professionnelle du Manuel MSD
21-hydroxylase deficiency: MedlinePlus Genetics
Frontiers | Long-Term Health Outcomes of Korean Adults With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
Management of endocrine immune-related adverse events of immune checkpoint inhibitors: an updated review in: Endocrine Connections Volume 9 Issue 10 (2020)
21-Hydroxylase - Wikipedia
MANAGEMENT OF ENDOCRINE DISEASE: Congenital adrenal hyperplasia due to 21- hydroxylase deficiency: update on the management of adult patients and prenatal treatment in: European Journal of Endocrinology Volume 176 Issue 4 (2017)
Congenital Adrenal Hyperplasias - The Medical Biochemistry Page
21-Hydroxylase - an overview | ScienceDirect Topics
French Endocrine Society Guidance on endocrine side effects of immunotherapy in: Endocrine-Related Cancer Volume 26 Issue 2 (2019)
21-Hydroxylase Deficiency - Pediatrics - Medbullets Step 2/3
Frontiers | Latent Adrenal Insufficiency: From Concept to Diagnosis
Pôle Biologie Pathologie Génétique > Ac anti-21 Hydroxylase
Immune Checkpoint Inhibitor-Induced Adrenalitis and Primary Adrenal Insufficiency: Systematic Review and Optimal Management - Endocrine Practice
Frontiers | Management of the Female With Non-classical Congenital Adrenal Hyperplasia (NCCAH): A Patient-Oriented Approach
Frontiers | 21-Hydroxylase-Specific CD8+ T Cells in Autoimmune Addison's Disease Are Restricted by HLA-A2 and HLA-C7 Molecules
Two novel <i>CYP21A2</i> missense mutations in Italian patients with 21â•' hydroxylase deficiency: Identificatio
Clinical advances in the pharmacotherapy of congenital adrenal hyperplasia in: European Journal of Endocrinology Volume 186 Issue 1 (2022)
